谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 154 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
The Efficacy and Safety of TACE or HAIC Combined with ICIs and Angiogenesis Inhibitors in Unresectable Hepatocellular Carcinoma
Qing Wu,Ping Li,Nan Lin, BinBin Mao,Xianhe Xie
Journal of immunotherapy (Hagerstown, Md 1997) (2025)
引用0浏览0WOS引用
0
0
Efficacy of Radiotherapy Combined with Targeted Therapy and Immunotherapy for Lymph Node Metastasis of Liver Cancer
Huamei Yan,Jianliang Xu,Zhenghuan Li, Nuoya Li, Xianyu Guo,Manya Wu, Donghui Wang,Nan Lin, Jie Dong,Xiangying Xu
Journal of Cancer Research and Clinical Oncologyno. 4 (2025): 1-14
引用0浏览0WOS引用
0
0
CircRNA-mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance Through the PSIP1/c-Myc Axis
Yongchang Tang,Feng Yuan,Mingbo Cao, Yupeng Ren, Yuxuan Li, Gaoyuan Yang,Zhaozhong Zhong,Hao Liang,Zhiyong Xiong,Zhiwei He,Nan Lin,Meihai Deng,Zhicheng Yao
Advanced science (Weinheim, Baden-Wurttemberg, Germany)no. 20 (2025): e2410591-e2410591
引用0浏览0WOS引用
0
0
Exosome-derived Lnc-Fam72d-3 Promotes Lenvatinib Resistance by Remodeling Hepatocellular Carcinoma Cytoskeleton Via MBNL1/FAK Axis
Mingbo Cao, Yuxuan Li, Xiaorui Su, Yongchang Tang, Yupeng Ren,Jing Luo,Feng Yuan, Gaoyuan Yang,Zhiwei He, Zheng Shi, Ziyi Hu, Guirong Liang,Qi Zhang,Meihai Deng,Zhicheng Yao,Nan Lin
Drug resistance updates reviews and commentaries in antimicrobial and anticancer chemotherapy (2025): 101271-101271
引用0浏览0WOS引用
0
0
加载更多
作者统计

#Papers: 154

#Citation: 1877

H-Index: 23

G-Index: 38

Sociability: 6

Diversity: 3

Activity: 16

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn